Show simple item record

dc.contributor.authorSmith, Een_US
dc.contributor.authorFox, Aen_US
dc.contributor.authorWillmers, Gen_US
dc.contributor.authorWright, Den_US
dc.contributor.authorStuart, Ben_US
dc.date.accessioned2023-03-23T15:44:21Z
dc.date.available2022-09-12en_US
dc.date.issued2022-10-14en_US
dc.identifier.issn2047-9956en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/85247
dc.description.abstractBACKGROUND: As cancer survivorship improves, pressure on oncology services to provide safe, timely treatments increases. Traditional manual compounding processes are error prone, putting patients at risk. Additionally, errors have a detrimental impact on service delivery and staff morale. Information technology is increasingly utilised to improve safety and service delivery of systemic anti-cancer therapy (SACT). The compounding process control system, Medcura, was developed to manage the end-to-end process and reduce transcription and calculation errors. OBJECTIVES: To evaluate the impact of implementing Medcura on internal errors and staff perceptions of errors. METHOD: An aseptic process control system, Medcura, was implemented in a busy pharmacy chemotherapy production unit. Internal error and severity data were collected and analysed for 14 months before and during implementation, and 24 months after implementation. In addition, one-to-one semi-structured interviews were carried out with pharmacy staff, pre- and post-implementation. Interviews were transcribed and thematically analysed. RESULTS: Error rates decreased after implementation from 2.9% to 2.1%. The types of error detected also changed with a decrease in worksheet and labelling errors, and an increase in assembly errors. The severity of the errors, as a percentage of total errors made, also decreased after implementation. Staff were predominantly positive about Medcura; it reduced the number of errors, eased the preparation of worksheets and labels, reduced pressure and work-related stress, and improved job satisfaction. CONCLUSIONS: Implementing Medcura has resulted in a reduction in both error rate and severity. Specifically, errors related to label and worksheet generation have seen the largest reduction. Staff have viewed these changes positively and report reduced levels of work-related stress. Further development and roll-out will improve patient safety and staff morale.en_US
dc.languageengen_US
dc.relation.ispartofEur J Hosp Pharmen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectDrug Compoundingen_US
dc.subjectMEDICAL ERRORSen_US
dc.subjectMEDICAL ONCOLOGYen_US
dc.subjectMEDICATION SYSTEMS, HOSPITALen_US
dc.subjectPHARMACEUTICAL PREPARATIONSen_US
dc.subjectPHARMACY ADMINISTRATIONen_US
dc.subjectQuality Assurance, Health Careen_US
dc.subjectSafetyen_US
dc.titleImpact of implementing the aseptic compounding management system, Medcura, on internal error rates within an oncology pharmacy aseptic unit: a mixed methods evaluation.en_US
dc.typeArticle
dc.identifier.doi10.1136/ejhpharm-2022-003377en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/36241376en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
dcterms.dateAccepted2022-09-12en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States